The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Debanjana Chatterjee's Stock Ratings
Jones Trading Analyst
Debanjana Chatterjee is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/17/2025
Overall Average Return
-32.2%
Smart Score
Overall Average Return Percentile
7th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | KALV | Buy Now | KalVista Pharma | $12.40 | 141.94% | Debanjana Chatterjee20% | $30 → $30 | Maintains | Buy | Get Alert |
| 03/13/2025 | CTNM | Buy Now | Contineum Therapeutics | $4.64 | 395.16% | Debanjana Chatterjee20% | → $23 | Initiates | → Buy | Get Alert |
| 01/27/2025 | SGMT | Buy Now | Sagimet Biosciences | $2.16 | 1844.44% | Debanjana Chatterjee20% | → $42 | Initiates | → Buy | Get Alert |
| 12/11/2024 | SYRE | Buy Now | Spyre Therapeutics | $12.70 | — | Debanjana Chatterjee20% | — | Initiates | → Hold | Get Alert |
| 09/27/2024 | KALV | Buy Now | KalVista Pharma | $12.40 | 182.26% | Debanjana Chatterjee20% | → $35 | Initiates | → Buy | Get Alert |
| 09/19/2024 | PHVS | Buy Now | Pharvaris | $14.15 | 225.09% | Debanjana Chatterjee20% | → $46 | Initiates | → Buy | Get Alert |
| 09/17/2024 | NTLA | Buy Now | Intellia Therapeutics | $7.14 | 474.23% | Debanjana Chatterjee20% | → $41 | Initiates | → Buy | Get Alert |
